Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative
- Supplementary File 1:
PDF-Document (PDF, 266 KiB)
Kochlik, B.; Stuetz, W.; Pérès, K.; Féart, C.; Tegner, J.; Rodriguez-Mañas, L.; Grune, T.; Weber, D. Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative. J. Clin. Med. 2019, 8, 1010. https://doi.org/10.3390/jcm8071010
Kochlik B, Stuetz W, Pérès K, Féart C, Tegner J, Rodriguez-Mañas L, Grune T, Weber D. Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative. Journal of Clinical Medicine. 2019; 8(7):1010. https://doi.org/10.3390/jcm8071010
Chicago/Turabian StyleKochlik, Bastian, Wolfgang Stuetz, Karine Pérès, Catherine Féart, Jesper Tegner, Leocadio Rodriguez-Mañas, Tilman Grune, and Daniela Weber. 2019. "Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative" Journal of Clinical Medicine 8, no. 7: 1010. https://doi.org/10.3390/jcm8071010